Sinus and Mastoid Procedures with CC/MCC DRG Reimbursement

Sinus and Mastoid Procedures with CC/MCC: Inpatient Reimbursement Overview

DRG 135 covers sinus and mastoid surgical procedures when a Complication or Comorbidity or Major Complication or Comorbidity is present, defining clinical scope and case complexity. This Diagnosis-Related Group matters for inpatient reimbursement because the Complication or Comorbidity or Major Complication or Comorbidity designation affects payment by reflecting higher anticipated resource use.

Customize your policy alerts

Sign up for Sinus and Mastoid Procedures with CC/MCC: Inpatient Reimbursement Overview policy alerts

Get alerted when relevant policies change without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

DRG 135 Overview

DRG 135 covers inpatient admissions for patients undergoing sinus and mastoid procedures when a Complication or Comorbidity or Major Complication or Comorbidity is present. These procedures include surgical management of chronic or acute disease processes of the paranasal sinuses and the mastoid portion of the temporal bone, often involving otolaryngology or otology teams. This Diagnosis-Related Group matters for Medicare payment because the presence of a Complication or Comorbidity or Major Complication or Comorbidity increases reimbursement relative to uncomplicated cases, reflecting higher expected resource use. Accurate clinical documentation and coding of the secondary diagnoses that qualify as Complication or Comorbidity or Major Complication or Comorbidity are therefore central to appropriate inpatient payment.

Sinus and Mastoid Procedures with CC/MCC: Inpatient Reimbursement Overview

Customize your policy alerts

Sign up for Sinus and Mastoid Procedures with CC/MCC: Inpatient Reimbursement Overview policy alerts

Get alerted when relevant policies change without checking for updates manually.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

DRG 135 Overview

Clinical Trials

Acute surgical technique and perioperative complication reduction trials: randomized or quasi-experimental studies that compare different operative approaches (for example endoscopic sinus surgery variations, mastoidectomy techniques, or adjunctive intraoperative measures) and perioperative protocols aimed at reducing bleeding, cerebrospinal fluid leak, facial nerve injury, or postoperative infection. These studies typically enroll hospitalized adults or children undergoing sinus or mastoid procedures with documented complications or comorbid conditions (the CC/MCC population), and measure short-term clinical endpoints such as intraoperative metrics, immediate complication rates, length of stay, and need for reoperation. Results inform surgeons and hospital administrators about techniques and processes that can lower acute morbidity and resource use in this high-acuity DRG.
Comparative effectiveness studies of perioperative medical management and antimicrobial strategies: prospective cohort studies or pragmatic randomized trials evaluating variations in preoperative optimization (such as management of anticoagulation, corticosteroid use, or diabetic control), intra- and postoperative antibiotic regimens, and topical therapies to prevent surgical site infection and persistent disease. These trials focus on patients with significant comorbidities or more extensive disease who fall into the CC/MCC grouping and assess outcomes including readmission, infection, antibiotic exposure, and total inpatient cost. Findings are directly relevant to payers and care managers because they identify medical-management approaches that may reduce complications, shorten stays, and decrease overall inpatient expenditures for this DRG.
Post-discharge functional outcomes and health-utilization studies: prospective observational or registry-based research tracking quality of life, symptom control (breath/sinus symptoms, hearing), need for revision surgery, outpatient rehabilitative services, and unplanned healthcare utilization over months to years after index sinus or mastoid procedures. These studies enroll the DRG population at discharge and stratify by presence of CC/MCCs, procedural complexity, and social determinants of health to determine predictors of long-term resource use and patient-reported outcomes. Results help providers and payers target post-acute care coordination, outpatient follow-up intensity, and bundled-payment or case-management strategies to reduce readmissions and improve value for patients within this diagnosis-related group.

Acute surgical technique and perioperative complication reduction trials: randomized or quasi-experimental studies that compare different operative approaches (for example endoscopic sinus surgery variations, mastoidectomy techniques, or adjunctive intraoperative measures) and perioperative protocols aimed at reducing bleeding, cerebrospinal fluid leak, facial nerve injury, or postoperative infection. These studies typically enroll hospitalized adults or children undergoing sinus or mastoid procedures with documented complications or comorbid conditions (the CC/MCC population), and measure short-term clinical endpoints such as intraoperative metrics, immediate complication rates, length of stay, and need for reoperation. Results inform surgeons and hospital administrators about techniques and processes that can lower acute morbidity and resource use in this high-acuity DRG.
Comparative effectiveness studies of perioperative medical management and antimicrobial strategies: prospective cohort studies or pragmatic randomized trials evaluating variations in preoperative optimization (such as management of anticoagulation, corticosteroid use, or diabetic control), intra- and postoperative antibiotic regimens, and topical therapies to prevent surgical site infection and persistent disease. These trials focus on patients with significant comorbidities or more extensive disease who fall into the CC/MCC grouping and assess outcomes including readmission, infection, antibiotic exposure, and total inpatient cost. Findings are directly relevant to payers and care managers because they identify medical-management approaches that may reduce complications, shorten stays, and decrease overall inpatient expenditures for this DRG.
Post-discharge functional outcomes and health-utilization studies: prospective observational or registry-based research tracking quality of life, symptom control (breath/sinus symptoms, hearing), need for revision surgery, outpatient rehabilitative services, and unplanned healthcare utilization over months to years after index sinus or mastoid procedures. These studies enroll the DRG population at discharge and stratify by presence of CC/MCCs, procedural complexity, and social determinants of health to determine predictors of long-term resource use and patient-reported outcomes. Results help providers and payers target post-acute care coordination, outpatient follow-up intensity, and bundled-payment or case-management strategies to reduce readmissions and improve value for patients within this diagnosis-related group.

OpenPayer

Sinus and Mastoid Procedures with CC/MCC: Inpatient Reimbursement Overview

Sign up for Sinus and Mastoid Procedures with CC/MCC: Inpatient Reimbursement Overview policy alerts

DRG 135 Overview

Catch payer policy changes before they impact reimbursement

Catch payer policy changes before they impact reimbursement

OpenPayer

Sinus and Mastoid Procedures with CC/MCC: Inpatient Reimbursement Overview

Sign up for Sinus and Mastoid Procedures with CC/MCC: Inpatient Reimbursement Overview policy alerts

DRG 135 Overview

Clinical Trials

Related Codes

References

Clinical Trials

Related Codes

References